Clinical effect of thiazolidinediones in subjects with disorders of carbohydrate metabolism in case of polymorphism rs1801282

BACKGROUND: The polymorphism rs1801282 (Pro12Ala) may be one of the reasons for the heterogeneous response of patients with carbohydrate metabolism disorders to thiazolidinedione therapy. Studies of this polymorphism in patients with metabolic syndrome (MS) will help identify a group of patients in...

Full description

Bibliographic Details
Main Authors: Tatyana V. Eremenko, Nikolay A. Matsievskiy, Natalya V. Vorokhobina, Irina Y. Matesius, Irina N. Abramashvili
Format: Article
Language:English
Published: Endocrinology Research Centre 2020-09-01
Series:Ожирение и метаболизм
Subjects:
Online Access:https://www.omet-endojournals.ru/jour/article/view/9943